ORMP · Oramed Pharmaceuticals Inc. · Share Buybacks
$4.42
-0.07 (-1.57%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$196.76M
Shares
41.60M
Volume · Oct 5
104.14K
Avg daily vol (3M)
199.66K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$469,000
as of 2026-03-31
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-03-18 | — | $75,000 | — | — | 10-K , filed 2026-03-26 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $4,741,000 | 10-K, filed 2026-03-26 |
| 2024-12-31 | $2,484,000 | 10-K, filed 2026-03-26 |